A Genetic Dissection of Antipsychotic Induced Movement Disorders
Journal:
Current Medicinal Chemistry
Volume:
20
Page:
312-330
Author(s):
C. Crisafulli, A. Drago, A. Sidoti and A. Serretti
Recent Patents on Drugs Addressing Neurodegenerative Diseases
Journal:
Recent Patents on Biomarkers
Volume:
3
Page:
25-35
Author(s):
Manuel Van Gijsel-Bonnello, Michel Khrestchatisky, Max de Reggi and Bouchra Gharib
Neuroferritinopathy: Update on Clinical Features and Pathogenesis
Journal:
Current Drug Targets
Volume:
13
Page:
1200-1203
Author(s):
Alisdair McNeill and Patrick F. Chinnery
Aceruloplasminemia
Journal:
Current Drug Targets
Volume:
13
Page:
1190-1199
Author(s):
Satoshi Kono
Pantothenate Kinase-Associated Neurodegeneration
Journal:
Current Drug Targets
Volume:
13
Page:
1182-1189
Author(s):
Monika B. Hartig, Holger Prokisch, Thomas Meitinger and Thomas Klopstock
Editorial (Hot Topic: Neurodegeneration with Brain Iron Accumulation)
Journal:
Current Drug Targets
Volume:
13
Page:
1181-1181
Author(s):
Hiroaki Miyajima
From Blood-to-Brain: Regulating the Permeability of the Blood-Brain Barrier
Journal:
Current Psychopharmacology
Volume:
1
Page:
214-227
Author(s):
B. Gomez-Gonzalez, K. Sanchez-Alegria and J. Velazquez-Moctezuma
Novel Drug Targets in Malaria Parasite with Potential to Yield Antimalarial Drugs with Long Useful Therapeutic Lives
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
3505-3521
Author(s):
Francis W. Muregi, Hannah Nyakio Wamakima and Francis T. Kimani
Antimalarial Drugs and their Useful Therapeutic Lives: Rational Drug Design Lessons from Pleiotropic Action of Quinolines and Artemisinins
Journal:
Current Drug Discovery Technologies
Volume:
7
Page:
280-316
Author(s):
Francis W. Muregi
Pantothenate Utilization by Plasmodium as a Target for Antimalarial Chemotherapy
Journal:
Infectious Disorders - Drug Targets
Volume:
10
Page:
200-216
Author(s):
C. Spry, D.A. van Schalkwyk, E. Strauss and K.J. Saliba